Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation Wee1 Inhibitor, Apr-1051, in Hpv+ Head and Neck Squamous Cell Carcinoma (Hnscc) in Collaboration With Md Anderson Cancer Center

THOMSON REUTERS
25 Jun

Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation Wee1 Inhibitor, Apr-1051, in Hpv+ Head and Neck Squamous Cell Carcinoma (Hnscc) in Collaboration With Md Anderson Cancer Center

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10